Breakthroughs and Market Evolution in Breast Cancer

On Demand

Duration: 30 Minutes

Original Date: December 09, 2024

First name

Last name

Email address

Business phone

Company

Job role

Industry

City

Country or Region

State or Province Optional

Yes, I would like to be contacted by a representative to learn more about Bloomberg's solutions and services.

What are you interested in learning more about?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

We will discuss the current landscape and upcoming clinical and regulatory catalyst in breast cancer research. We will also preview key data due at the San Antonio Breast Cancer conference as antibody-drug conjugates look to change therapy for a broader set of patients.

Speakers

Max Nisen

Analyst

Bloomberg Intelligence

Tonia Kefala Stavridi

Disease Specialist

Bloomberg Intelligence

Tonia is a Disease Specialist under the Pharma & Biotech team at Bloomberg Intelligence, with a focus on breast cancer including analysis and curation of clinical data, disease epidemiology and addressable market opportunities. She holds a PhD in Biochemistry and MPhil in Biological Sciences from University of Cambridge as well as a BSc in Biotechnology from Imperial College London.

Breakthroughs and Market Evolution in Breast Cancer

Speakers

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.